Mihaela Poroch
Overview
Explore the profile of Mihaela Poroch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
5
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bacoanu G, Poroch V, Anitei M, Poroch M, Froicu E, Pascu A, et al.
Healthcare (Basel)
. 2024 Aug;
12(16).
PMID: 39201152
Background: End-of-life care raises ethical, moral, legal and economic dilemmas, especially when physicians have to decide whether to initiate or to stop treatments that may be considered disproportionate and futile....
2.
Bacoanu G, Poroch V, Anitei M, Poroch M, Froicu E, Hanganu B, et al.
Healthcare (Basel)
. 2024 Aug;
12(16).
PMID: 39201143
Background: Spiritual care for patients at the end of life is an important element in their holistic care. The aim of this study is to assess the opinions of cancer...
3.
Pasa V, Popa E, Poroch M, Cosmescu A, Bacusca A, Slanina A, et al.
Medicina (Kaunas)
. 2023 Jun;
59(6).
PMID: 37374366
Classic polyarteritis nodosa (PAN) is a vasculitis with systemic manifestations that is characterized by inflammatory and necrotizing lesions affecting medium and small muscular arteries, most frequently at the bifurcation of...
4.
Popa E, Tetia T, Poroch M, Ungureanu M, Cosmescu A, Barbacariu L, et al.
Cureus
. 2022 Dec;
14(11):e31331.
PMID: 36514571
Background In Romania, as in other parts of the world, the family doctor is the first to make contact with a healthy patient and is also the first to notice...
5.
Anton I, Mititelu-Tartau L, Popa E, Poroch M, Poroch V, Pelin A, et al.
Medicina (Kaunas)
. 2022 Nov;
58(11).
PMID: 36363577
: Diabetes mellitus (DM) is a complex disease affecting the whole metabolic balance of the body and resulting in multiple organ complications: cardiovascular, neuronal, renal, etc. Our study focuses on...
6.
Anton I, Mititelu-Tartau L, Popa E, Poroch M, Poroch V, Pintilei D, et al.
Healthcare (Basel)
. 2022 Jul;
10(7).
PMID: 35885680
(1) Background. We aimed to assess long-term efficacy and safety in inadequately controlled type 2 diabetes (T2DM) of two SGLT-2 inhibitors: empagliflozin (Empa) and dapagliflozin (Dapa), combined with metformin, other...